EP Patent

EP1744757A4 — Improved nsaid composition

Assigned to Equitech Corp · Expires 2009-04-22 · 17y expired

What this patent protects

Patent listed against Mobic.

Drugs covered by this patent

Mobic (MELOXICAM) · Boehringer Ingelheim

Patent Metadata

Patent number: EP1744757A4
Jurisdiction: EP
Classification: —
Expires: 2009-04-22
Drug substance claim: No
Drug product claim: No
Assignee: Equitech Corp
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.